Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,591
Closed -$478K 1551
2025
Q4
$478K Sell
14,591
-42,988
-75% -$1.06M 0.01% 1249
2025
Q3
$1.03M Sell
57,579
-103,852
-64% -$1.51M 0.02% 958
2025
Q2
$1.75M Buy
+161,431
New +$2.11M 0.04% 669
2025
Q1
Sell
-14,285
Closed -$235K 1195
2024
Q4
$235K Buy
+14,285
New +$202K 0.02% 1008
2024
Q2
Sell
-23,562
Closed -$190K 1389
2024
Q1
$190K Sell
23,562
-1,562
-6% -$14K 0.01% 1169
2023
Q4
$172K Buy
25,124
+2,462
+11% +$13.7K 0.02% 1030
2023
Q3
$113K Buy
+22,662
New +$157K 0.01% 959

Other funds holding AXGN

Y-Intercept (HK)'s AXGN Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Axogen (AXGN) in Q1 2026, closing a stake of 14,591 shares — an estimated $478K sold.

Y-Intercept (HK) first reported a position in AXGN in Q3 2023 and held it in 7 quarters. The position peaked at $1.75M in Q2 2025. 222 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Y-Intercept (HK) reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 14,591 Axogen shares in Q1 2026, an estimated $478K.
  • Y-Intercept (HK) first reported a position in Axogen in Q3 2023 and held it in 7 quarters.
  • Y-Intercept (HK)'s Axogen position peaked at $1.75M in Q2 2025.
  • 222 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.